CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Bladder Cancer

Oncology NEWS International. Vol. 17 No. 1
RESEARCH REPORT 

Broccoli Sprouts Extract Might Lower Bladder Cancer Risk

January 1, 2008

PHILADELPHIA—Eating a concentrated extract of freeze-dried broccoli sprouts might inhibit bladder cancer by delivering a protective factor right where the bladder is most at risk. Eating three helpings a month of raw (but not cooked) cruciferous vegetables might reduce bladder cancer risk, researchers reported at the AACR's 6th Annual International Conference on Frontiers in Cancer Prevention Research.

A research team led by Rex Munday, PHD, from Ruakura Agricultural Research Center, Hamilton, New Zealand, induced bladder cancer in rats and had them eat a freeze-dried aqueous extract of broccoli sprouts. They found that the incidence, multiplicity, size, and progression of bladder cancer were all inhibited by the extract, which caused no histological changes in the bladder (abstract B149).

"This extract cut cancer incidence by 2.6-fold, inhibited cancer progression, and caused no adverse effects in the bladder," senior author Yuesheng Zhang, MD, PHD, professor in the Department of Cancer Prevention and Control, Ros-well Park Cancer Institute, said at an AACR press briefing. Dr. Zhang said that broccoli sprouts have 30 times more isothiocyanates (ITCs) than mature broccoli, and the freeze-dried extract had 600 times more ITCs by weight than fresh whole broccoli.

More than 70% of the ingested ITCs were excreted in the urine within 12 hours after a single oral dose. Urinary ITC levels were two to three orders of magnitude higher than plasma concentrations in the treated rats, and bladder tissue ITC levels were also higher than hepatic ITC levels, indicating that ITCs from the extract are selectively delivered to the bladder epithelium through urinary excretion.

Raw better than cooked

A related study, also from Roswell Park researchers, suggests that the way cruciferous vegetables are prepared may have major effects on their anticancer properties (abstract B47).

Li Tang, MD, PHD, and her colleagues conducted a case-control study of 275 patients with incident primary bladder cancer and 825 cancer-free controls to determine whether the inconsistent results of previous studies of cruciferous vegetable intake and bladder cancer risk were due to differences in how the vegetables were prepared. Patients completed a comprehensive questionnaire that included prediagnosis diet, occupational exposure, and other bladder cancer risk factors such as smoking history.

"Cooking can substantially reduce or destroy ITCs, and could account for study inconsistencies," said Dr. Tang, a postdoctoral fellow in the Department of Cancer Prevention and Control.

Bladder cancer risk was significantly reduced by intake of raw cruciferous vegetables (adjusted odds ratio [OR] for highest vs lowest category, 0.57). This did not apply to cooked cruciferous vegetables. There appeared to be a dose-response trend (P = .004). Total fruit, total vegetable, and total cruciferous vegetable intakes had no significant effect on bladder cancer risk.

Nonsmokers who ate three or more servings monthly of raw cruciferous vegetables had the greatest risk reduction (adjusted OR, 0.27), compared to smokers with lower cruciferous vegetable intake.

"Raw cruciferous vegetables such as broccoli, cabbage, and cauliflower are better than their cooked counterparts in terms of bladder cancer prevention. Intake of three or more helpings of such vegetables per month may reduce the risk of bladder cancer by 37%. Smokers, even heavy smokers, may benefit from the intake of raw cruciferous vegetables. Risk reduction for smokers was 40% to 54%," Dr. Tang said at the press briefing.

Ernest T. Hawk, MD, MPH, head of the Division of Cancer Prevention and Population Sciences, M.D. Anderson Cancer Center, put the two vegetable studies into perspective for ONI.

"ITCs are well known to inhibit cancer development in vitro by modifying the metabolism of carcinogens," he said. "The Zhang study addresses a key preliminary question before contemplating large-scale trials in humans. It shows that the active substance in broccoli sprouts, ITCs, becomes concentrated in the urine, which suggests that it may be particularly effective at inhibiting bladder cancer.

The study of cooked vs raw cruciferous vegetable intake is useful for hypothesis generation, but should not be the basis for recommendations to the public because it is a retrospective observational study, he said. Dr. Hawk also wondered how many other variables had been included in the analysis and how many times the data had been sliced. "The more things you look at, the more likely you are to find something statistically significant purely by chance, which is one of the reasons that we typically do not make recommendations to the public based on observational studies alone," he said. A major potential confounder that should be explored in future studies is whether consumption of raw cruciferous vegetables is just a marker for a generally more healthy lifestyle.

The most intriguing aspect of this study is that it might help explain the conflicting conclusions about cruciferous vegetables and cancer protection reported by other studies: "Maybe the key factor is whether they are cooked vs raw," he said.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

Advanced Urothelial Carcinoma: Moving the Field Forward
ONCOLOGY,  March 12, 2013
Targeted Therapy in Advanced Urothelial Carcinoma
ONCOLOGY,  March 12, 2013
ASCO GU: Clinical Staging in Bladder Cancer Inaccurate Nearly Half of the Time
February 19, 2013
ASCO GU: MVAC Safe Alternative for Neoadjuvant Treatment of Invasive Bladder Cancer
February 19, 2013
Markers Can ID Aggressive Smoking-Associated Bladder Cancer
January 17, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter


CancerNetwork on Facebook
 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Bladder Cancer
Evidence on Bladder Cancer
Guidelines on Bladder Cancer
Patient Education on Bladder Cancer
Clinical Trials on Bladder Cancer
Practical Articles on Bladder Cancer
Research and Reviews on Bladder Cancer
All "Bladder Cancer" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy